StonvexLoading…
StonvexStonvexStonvexCore line items from NTRA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $696.64M | $2.31B | $1.64B | $1.05B |
Operating Income | $-93.52M | $-309.91M | $-287.13M | $-189.55M |
Net Income | $-85.09M | $-208.16M | $-255.42M | $-167.87M |
EPS (Diluted) | $-0.60 | $-1.52 | $-1.88 | $-1.24 |
Total Assets | $2.61B | $2.40B | $1.82B | $1.76B |
Total Liabilities | $840.38M | $685.93M | $569.29M | $510.88M |
Cash & Equivalents | $1.09B | $1.08B | $1.04B | $1.00B |
Free Cash Flow OCF − CapEx | $18.03M | $109.11M | $71.30M | $34.31M |
Shares Outstanding | 142.73M | 139.69M | 137.53M | 136.76M |